drugset / Trial / NCT06372184

Washed Microbiota Transplantation for Allergic Rhinitis

NCT06372184

Not yet recruiting 32 enrolled The Second Hospital of Nanjing Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

Allergic rhinitis (AR) is characterized by sneezing, nasal congestion, nasal itching and nasal leakage and is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Increasing evidence showed that gut microbiota could influence the development of AR, and we found that washed microbiota transplantation (WMT) could improve nasal symptoms in clinical practice. This clinical trial aims to evaluate the efficacy and safety of WMT for AR.

Timeline

Start
2024-06-01
Primary completion
2029-06-01
Completion
2029-10-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified Oral

Indications